Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltamivir Combined With High-dose Dexamethasone in Immune Thrombocytopenia
NCT01965626Phase 2Completed
- Sponsor
- Shandong University
- Start
- Feb 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oseltamivir in immune thrombocytopenia (ITP), sponsored by Shandong University. Started Feb 2016; status: completed.
02
Drugs
oseltamivir
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT01965626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01965626.